Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-021808

Chief Scientific Officer sold 3,025 shares at $30.00 ($90,751)

From the SEC's structured data for this filing

Trades in this filing

Leen Ann M. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-16 Sale : show line 1 in the form −3,025 $30.00 $90,751 2,459,142 I
Open-market sales · 3,025 sh · avg $30.00 · $90,751
Loading xslF345X03/doc4.xml…